文献速递青光眼

日本人群原发性开角型青光眼的遗传风险分层

Genetic Risk Stratification of Primary Open-Angle Glaucoma in Japanese Individuals.
PubMed 文献 · Ophthalmology · 2024-07-17

该横断面分析基于日本人群原发性开角型青光眼(POAG)全基因组关联研究构建遗传风险评分(GRS),在3625名日本个体中筛选模型,并在JGS-OG与GRC-JOS数据集及久山研究人群中验证。采用98个变异、在国际青光眼遗传学联盟GWAS中达全基因组显著性的GRS判别准确性最佳(AUC 0.65)。日本东北人群中GRS最高10%者POAG比例显著高于最低10%(OR 6.15,95%CI 4.35-8.71),但一般人群分层判别性能较弱(AUC 0.56)。

要点

  • 基于98个IGGC全基因组显著变异的GRS判别准确性最佳,AUC为0.65。
  • 日本东北人群中GRS最高10%者POAG比例显著高于最低10%(OR 6.15,95%CI 4.35-8.71)。
  • 一般人群中GRS最高20%者POAG患病率显著高于最低20%(9.2% vs 5.0%),但AUC仅0.56。

核心结论

  • GRS在日本人群中对POAG显示中等判别准确性,但一般人群风险分层判别性能相对较弱。

研究设计与样本

  • 横断面分析,基于日本人群POAG的GWAS构建GRS。
  • 模型选择使用3625名日本个体(1191例患者、2434名对照,日本东北人群)。
  • 判别准确性在1034例患者和1147名对照(JGS-OG与GRC-JOS)及久山研究1900名参与者中评估。

主要发现

  • 使用98个在IGGC中达全基因组显著性的变异构建的GRS判别准确性最佳(AUC 0.65)。
  • 日本东北人群中GRS最高10%者POAG比例显著高于最低10%(OR 6.15,95%CI 4.35-8.71)。
  • JGS-OG与GRC-JOS中GRS影响相似(AUC 0.64;最高 vs 最低十分位OR 5.81,95%CI 3.79-9.01)。
  • 久山研究中GRS最高20%者POAG患病率显著高于最低20%(9.2% vs 5.0%),但判别准确性低(AUC 0.56)。
  • POAG GRS与眼压(r=0.08,P=4.0×10⁻⁴)及垂直杯盘比(r=0.11,P=4.0×10⁻⁶)呈正相关。

关键数值与推荐

  • GRS使用98个在IGGC GWAS中与POAG相关且达全基因组显著性的变异。
  • 日本东北人群GRS最高10% vs 最低10%的POAG OR为6.15(95%CI 4.35-8.71)。
  • JGS-OG与GRC-JOS中GRS最高十分位 vs 最低十分位OR为5.81(95%CI 3.79-9.01),AUC为0.64。
  • 久山研究GRS最高20% vs 最低20%的POAG患病率为9.2% vs 5.0%,AUC为0.56。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To assess the impact of genetic risk estimation for primary open-angle glaucoma (POAG) in Japanese individuals. DESIGN: Cross-sectional analysis. PARTICIPANTS: Genetic risk scores (GRSs) were constructed based on a genome-wide association study (GWAS) of POAG in Japanese people. A total of 3625 Japanese individuals, including 1191 patients and 2434 controls (Japanese Tohoku), were used for the model selection. We also evaluated the discriminative accuracy of constructed GRSs in a dataset comprising 1034 patients and 1147 controls (the Japan Glaucoma Society Omics Group [JGS-OG] and the Genomic Research Committee of the Japanese Ophthalmological Society [GRC-JOS]) and 1900 participants from a population-based study (Hisayama Study). METHODS: We evaluated 2 types of GRSs: polygenic risk scores using the pruning and thresholding procedure and a GRS using variants associated with POAG in the GWAS of the International Glaucoma Genetics Consortium (IGGC). We selected the model with the highest areas under the receiver operating characteristic curve (AUC). In the population-based study, we evaluated the correlations between GRS and ocular measurements. MAIN OUTCOME MEASURE: Proportion of patients with POAG after stratification according to the GRS. RESULTS: We found that a GRS using 98 variants, which showed genome-wide significance in the IGGC, showed the best discriminative accuracy (AUC, 0.65). In the Japanese Tohoku, the proportion of patients with POAG in the top 10% individuals was significantly higher than that in the lowest 10% (odds ratio [OR], 6.15; 95% confidence interval [CI], 4.35-8.71). In the JGS-OG and GRC-JOS, we confirmed similar impact of POAG GRS (AUC, 0.64; OR [top vs. bottom decile], 5.81; 95% CI, 3.79-9.01). In the population-based study, POAG prevalence was significantly higher in the top 20% individuals of the GRS compared with the bottom 20% (9.2% vs. 5.0%). However, the discriminative accuracy was low (AUC, 0.56). The POAG GRS was correlated positively with intraocular pressure (r = 0.08: P = 4.0 × 10-4) and vertical cup-to-disc ratio (r = 0.11; P = 4.0 × 10-6). CONCLUSIONS: The GRS showed moderate discriminative accuracy for POAG in the Japanese population. However, risk stratification in the general population showed relatively weak discriminative performance. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Akiyama M, Tamiya G, Fujiwara K, et al. Genetic Risk Stratification of Primary Open-Angle Glaucoma in Japanese Individuals. Ophthalmology. 2024. PMID: 39023470. doi:10.1016/j.ophtha.2024.05.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。